Abstract:In vitro tests for controlled release PLGA microspheres in their current state often do not accurately predict in vivo performance of these products during formulation development. Here, we introduce a new mechanistic and multi-phase approach to more clearly understand in vitro-in vivo relationships, and describe the first "in vitro phase" with the model drug, triamcinolone acetonide (Tr-A). Two microsphere formulations encapsulating Tr-A were prepared from PLGAs of different molecular weights and end-capping (18kDa acid-capped and 54kDa ester-capped). In vitro release kinetics and the evidence for controlling mechanisms (i.e., erosion, diffusion, and water-mediated processes) were studied in four release media: PBST pH 7.4 (standard condition), PBST pH 6.5, PBS+1.0% triethyl citrate (TC), and HBST pH 7.4. The release mechanism in PBST was primarily polymer erosion-controlled as indicated by the similarity of release and mass loss kinetics. Release from the low MW PLGA was accelerated at low pH due to increased rate of hydrolysis and in the presence of the plasticizer TC due to slightly increased hydrolysis and much higher diffusion in the polymer matrix. TC also increased release from the high MW PLGA due to increased hydrolysis, erosion, and diffusion. This work demonstrates how in vitro conditions can be manipulated to change not only rates of drug release from PLGA microspheres but also the mechanism(s) by which release occurs. Follow-on studies in the next phases of this approach will utilize these results to compare the mechanistic data of the Tr-A/PLGA microsphere formulations developed here after recovery of microspheres in vivo. This new approach based on measuring mechanistic indicators of release in vitro and in vivo has the potential to design better, more predictive in vitro release tests for these formulations and potentially lead to mechanism-based in vitro-in vivo correlations.

RELEASE OF MITOXANTRONE FROM MITOXANTRONE ALBUMIN MICROSPHERES AND GALACTOSYL-MITOXANTRONEALBUMIN MICROSPHERES IN VITRO

Study on mitoxantrone albumin microspheres for liver targeting

STUDY ON THE DRUG RELEASE IN VITRO OF MITOXANTRONE STARCH MICROSPHERE

Study on preparation and release of mitoxantrone transfersomes in vitro

[Study on Pharmacokinetics of Mitoxantrone Polycyanoacrylate Nanoparticles Freeze-Dried Injection by HPLC Column Switching Technique].

Release Profile of Compound Liposomes Entrapped with Vincristine Sulfate and Mitoxantrone Chlorhydric Acid in Vitro and Their Distribution in Mice

[Study on the Mitoxantrone Ethylcellulose Microspheres for Liver Artery Embolization].

[Study on Mitoxantrone Polycyanoacrylate Nanospheres].

PREPARATION OF LONG CIRCULATING MITOXANTRONE LIPOSOMES AND ITS PHARMACOKINETICS

Quantification of paclitaxel in rat plasma by LC-MS/MS and pharmacokinetics of paclitaxel thermosensi-tive liposomes in rats

[Structure Charateristics of Mitoxantrone Transforsomes].

Preparation and the Release Properties of Mitomycin-Loaded Albumin Microspheres in Vitro

[Effect of Preparation Technique on in Vitro Release Mechanism of Huperzine A Microspheres].

Preparation and Evaluation in Vitro and in Vivo of Docetaxel Loaded Mixed Micelles for Oral Administration.

Mechanistic Analysis of Triamcinolone Acetonide Release from PLGA Microspheres As a Function of Varying in Vitro Release Conditions.

Tissue Distribution and Pharmacodynamics of Chitosan-Coated Mitoxantrone Liposomes in the Tumor-Bearing Mice

Study of the in Vitro and in Vivo Pharmaceutical Behaviors of Monoammonium Glycyrrhizinate Liposome

The Release Characteristics of Different Model Drugs from Medicated PLGA Microspheres

Preparation and in Vitro Evaluation of Pro-Mixed Docetaxel Micelles

Preparation of mitoxantrone liposomes and study on its in vivo distribution in rats after transdermal delivery]

Comparison of the Degradation and Release Behaviors of Poly(lactide‐co‐glycolide)–methoxypoly(ethylene Glycol) Microspheres Prepared with Single‐ and Double‐emulsion Evaporation Methods